Symptoms of COVID-19
| . | All Patients (N = 250), n (%) . | Moderate or severe COVID-19 (n = 168), n (%) . |
|---|---|---|
| Symptom | ||
| Fever | 171 (73) | 131 (80) |
| Cough | 155 (67) | 107 (65) |
| Shortness of breath | 117 (50) | 95 (58) |
| Fatigue | 93 (40) | 76 (46) |
| Myalgias | 51 (22) | 38 (23) |
| Headache | 39 (17) | 23 (14) |
| Diarrhea | 32 (14) | 25 (15) |
| Nausea/vomiting | 21 (9) | 14 (9) |
| Rhinorrhea | 21 (9) | 8 (5) |
| Anosmia | 13 (6) | 6 (4) |
| Confusion | 14 (6) | 13 (8) |
| Diaphoresis | 13 (6) | 10 (6) |
| Abdominal pain | 12 (5) | 10 (6) |
| Weight loss | 5 (2) | 2 (1) |
| No symptoms | 7 (3) | 2 (1) |
| Unknown/no response | 17 (7) | 4 (2) |
| Time to symptom resolution, d | ||
| ≤2 | 24 (10) | 18 (11) |
| 3-5 | 39 (16) | 24 (14) |
| 6-10 | 34 (14) | 23 (14) |
| 11-20 | 56 (22) | 44 (26) |
| 21-30 | 30 (12) | 24 (14) |
| >30 | 16 (6) | 11 (7) |
| No symptoms | 14 (6) | 3 (2) |
| Unknown/no response | 37 (15) | 21 (13) |
| . | All Patients (N = 250), n (%) . | Moderate or severe COVID-19 (n = 168), n (%) . |
|---|---|---|
| Symptom | ||
| Fever | 171 (73) | 131 (80) |
| Cough | 155 (67) | 107 (65) |
| Shortness of breath | 117 (50) | 95 (58) |
| Fatigue | 93 (40) | 76 (46) |
| Myalgias | 51 (22) | 38 (23) |
| Headache | 39 (17) | 23 (14) |
| Diarrhea | 32 (14) | 25 (15) |
| Nausea/vomiting | 21 (9) | 14 (9) |
| Rhinorrhea | 21 (9) | 8 (5) |
| Anosmia | 13 (6) | 6 (4) |
| Confusion | 14 (6) | 13 (8) |
| Diaphoresis | 13 (6) | 10 (6) |
| Abdominal pain | 12 (5) | 10 (6) |
| Weight loss | 5 (2) | 2 (1) |
| No symptoms | 7 (3) | 2 (1) |
| Unknown/no response | 17 (7) | 4 (2) |
| Time to symptom resolution, d | ||
| ≤2 | 24 (10) | 18 (11) |
| 3-5 | 39 (16) | 24 (14) |
| 6-10 | 34 (14) | 23 (14) |
| 11-20 | 56 (22) | 44 (26) |
| 21-30 | 30 (12) | 24 (14) |
| >30 | 16 (6) | 11 (7) |
| No symptoms | 14 (6) | 3 (2) |
| Unknown/no response | 37 (15) | 21 (13) |
Patients were included only if symptoms or no symptoms were reported.